Mr. Bien has 34 years of experience in the pharmaceutical and biotech industry, and has worked in preclinical microbiology, anti-infective and oncology clinical research, project management, and managed a Phase I Research Clinic. Prior to joining Amplyx, Mr. Bien held positions at Warner-Lambert/Parke-Davis, DepoTech, Agouron, Pfizer, Trius Therapeutics and Progenity. While at Pfizer, he served as a research team leader and exploratory development director leading several oncology drug development teams. He has been involved in a number of successful drug development programs including Penetrex®, Sparfloxacin®, Cefzon®, Viracept®, Sutent®, Inlyta® and Sivextro®.
Mr. Bien received his B.S. in microbiology and public health from Michigan State University and his M.S. from the University of Michigan in clinical trial design and statistical analysis.